2,3-dihydroxypyridine has been researched along with vorinostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kornacki, JR; Mrksich, M; Oyelere, AK; Patil, V; Sodji, QH | 1 |
| Jain, S; Kornacki, JR; Mrksich, M; Oyelere, AK; Patil, V; Sodji, Q; Tekwani, BL | 1 |
2 other study(ies) available for 2,3-dihydroxypyridine and vorinostat
| Article | Year |
|---|---|
3-Hydroxypyridin-2-thione as novel zinc binding group for selective histone deacetylase inhibition.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Intracellular Space; Molecular Docking Simulation; Protein Conformation; Pyridines; Pyridones; Structure-Activity Relationship; Substrate Specificity; Thiones; Zinc | 2013 |
The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors.
Topics: Antiprotozoal Agents; Dose-Response Relationship, Drug; Histone Deacetylase Inhibitors; Histone Deacetylases; Isoenzymes; Leishmania donovani; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship | 2014 |